Exploring Real-World Atopic Dermatitis Treatment Patterns

home / between-the-lines / exploring-real-world-atopic-dermatitis-treatment-patterns

Gary M. Owens, MD, and Lawrence Eichenfield, MD, discuss how an atopic dermatitis therapy demonstrates significant clinical efficacy through targeted JAK inhibition, providing sustained symptom relief, reduced healthcare utilization, and decreased steroid dependency across diverse patient populations as evidenced by 18-month retrospective claims analysis.

© 2025 MJH Life Sciences

All rights reserved.